Description
PRINCIPIO ACTIVO: CLEBOPRIDA
PRINCIPIO ACTIVO: VILDAGLIPTINA - METFORMINA
Riesgo de reacciones alérgicas o hipersensibilidad
Riesgo de anemia
PRINCIPIO ACTIVO: GLICEROL
GELEVONO/ETINIIFA0.15/0.03MG-TAB21 MONTELUKAST 4.00 MG PRINCIPIO ACTIVO: CLEBOPRIDA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
























